Repligen

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Repligen and other ETFs, options, and stocks.

About RGEN

Repligen Corp. provides bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. It serves through the following product lines: Chromatography, Filtration, Process Analytics, and Proteins. 

CEO
Tony J. Hunt
CEOTony J. Hunt
Employees
1,852
Employees1,852
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
1981
Founded1981
Employees
1,852
Employees1,852

RGEN Key Statistics

Market cap
9.54B
Market cap9.54B
Price-Earnings ratio
59.43
Price-Earnings ratio59.43
Dividend yield
Dividend yield
Average volume
603.78K
Average volume603.78K
High today
$173.83
High today$173.83
Low today
$168.81
Low today$168.81
Open price
$170.24
Open price$170.24
Volume
261.98K
Volume261.98K
52 Week high
$300.23
52 Week high$300.23
52 Week low
$137.21
52 Week low$137.21

RGEN News

Simply Wall St 7d
Declining Stock and Decent Financials: Is The Market Wrong About Repligen Corporation?

It is hard to get excited after looking at Repligen's (NASDAQ:RGEN) recent performance, when its stock has declined 22% over the past three months. However, the...

Declining Stock and Decent Financials: Is The Market Wrong About Repligen Corporation?

Analyst ratings

90%

of 10 ratings
Buy
90%
Hold
10%
Sell
0%

RGEN Earnings

$0.00
$0.31
$0.61
$0.92
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 16, Pre-Market
ActualExpected Feb 16, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.